ArticleDrug safety2018

A Programme for Risk Assessment and Minimisation of Progressive Multifocal Leukoencephalopathy Developed for Vedolizumab Clinical Trials.

Asit Parikh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.